TENS Improves Cisplatin-Induced Neuropathy in Lung Cancer Patients
<i>Background:</i> Cisplatin-induced peripheral neuropathy is a common complication of cisplatin therapy, which develops in most patients with lung cancer. There are no effective preventive measures and once it occurs there is no effective therapy, except symptomatic. In this study, we a...
Main Authors: | Sanja Tomanovic Vujadinovic, Nela Ilic, Ivan Selakovic, Una Nedeljkovic, Nevena Krstic, Natasa Mujovic, Emilija Dubljanin Raspopovic, Dragana Jovanovic |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1648-9144/58/10/1405 |
Similar Items
-
Milnacipran Has an Antihyperalgesic Effect on Cisplatin-Induced Neuropathy
by: Sun Jin Cho, et al.
Published: (2023-08-01) -
The Role of Nucleotide Excision Repair in Cisplatin-Induced Peripheral Neuropathy: Mechanism, Prevention, and Treatment
by: Scarlett Acklin, et al.
Published: (2021-02-01) -
Impact of Chemotherapy-Induced Peripheral Neuropathy on the Quality of Life in Cancer Patients
by: Marica Novak, et al.
Published: (2022-01-01) -
New Insights into Potential Prevention and Management Options for Chemotherapy-Induced Peripheral Neuropathy
by: Janet Schloss, et al.
Published: (2016-01-01) -
Tempol improves optic nerve histopathology and ultrastructures in cisplatin-induced optic neuropathy in rats by targeting oxidative stress—Endoplasmic reticulum stress—Autophagy signaling pathways
by: Amira Ebrahim Alsemeh, et al.
Published: (2023-10-01)